GLP-1 is deactivated by dipeptidyl peptidase IV (DPP-IV), which cleaves off the two NH2-terminal amino acid residues, transforming the peptide into an antagonist of the GLP-1 receptor
Obesity 30(4):841857 Coulter AA, Rebello CJ, Greenway FL (2018) Centrally acting drugs for obesity: past, present, and future
V., Lalic, K
A statelicensed healthcare provider will carefully review your health history, weight loss goals, and individual needs to determine if GLP1 treatment is right for you
While the precise mechanism of NAION remains unknown, the effects of GLP-1 on vascular function, glucose homeostasis, and neuroprotection may potentially influence NAION development
GLP-1 Medications GLP-1 medications help support appetite regulation and blood sugar control to promote steady, sustainable weight management